Arab Drug Company for Pharmaceuticals and Chemical Industries SAE EGX:ADCI:
ARAB DRUG H1 NET PROFIT AFTER TAX EGP 134.6 MILLION
ARAB DRUG H1 REVENUE EGP 673.7 MILLION
Arab Drug H1 Profit EGP 134.6 Mln
Story so far
Earlier from Arab Pharmaceuticals
Later from Arab Pharmaceuticals
- Arab Pharmaceuticals (ADCI.CA) - Central Authority of Accountancy Report on Corporate Governance Report
- Arab Pharmaceuticals (ADCI.CA) - The Central Authority of Accountancy Report
- Arab Pharmaceuticals (ADCI.CA) - AGM Invitation
- Release from Arab Pharmaceuticals (ADCI.CA)
- Release from Arab Pharmaceuticals (ADCI.CA) Concerning the Company's Regulatory Framework
Follow Arab Pharmaceuticals into a list and get an email when it puts out news.
Follow Arab Pharmaceuticals